This site is intended for US healthcare professionals

Congresses

The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.

This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.

ENCORE POSTER
Use of Long-Acting Antipsychotic Treatments in Community Telepsychiatry: Study to Assess Knowledge, Attitudes, and Perceived Barriers From Patients’, Caregivers’, and Providers’ Perspective in South Carolina (LATITUDE Study)
Author(s):

Meera Narasimhan,1 Suzanne Hardeman,1 Casey Childers,1 Amanda Edgar,1 Amy Claxton,2* Elizabeth Keane,2 Batool A. Haider,2 Brittany D. Roy,2* Cory Saucier,3 Sergey Yagoda2

1Prisma Health - University of South Carolina Medical Group, Columbia, SC, USA; 2Alkermes, Inc., Waltham, MA, USA; 3QualityMetric Inc, LLC, Johnston, RI, USA

*AC and BDR were employees of Alkermes, Inc., at the time of the study

Content available until 05/30/2025